Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review

The treatment of lung cancer has changed drastically in recent years owing to the advent of immune checkpoint inhibitors (ICIs). A 1992 study reported that programmed cell death-1 (PD-1), an immune checkpoint molecule, is upregulated during the induction of T cell death. Since then, various immunore...

Descripción completa

Detalles Bibliográficos
Autores principales: Onoi, Keisuke, Chihara, Yusuke, Uchino, Junji, Shimamoto, Takayuki, Morimoto, Yoshie, Iwasaku, Masahiro, Kaneko, Yoshiko, Yamada, Tadaaki, Takayama, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290914/
https://www.ncbi.nlm.nih.gov/pubmed/32384677
http://dx.doi.org/10.3390/jcm9051362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290914/
https://www.ncbi.nlm.nih.gov/pubmed/32384677
http://dx.doi.org/10.3390/jcm9051362

Ejemplares similares